Rheum for Everyone, Episode 24 (video)| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

How the Experts Treat Sjögren’s Disease

Samantha C. Shapiro, MD  |  August 26, 2025

Inflammatory Arthritis

When SjD patients present with inflammatory arthritis, Dr. DiRenzo uses a combination of leflunomide and hydroxychloroquine, citing supportive data from a 2020 Lancet Rheumatology article.5 Methotrexate is also an option for those with significant joint involvement.

Dr. DiRenzo

Biologics are reserved for refractory cases of inflammatory arthritis. “If there are prominent glandular symptoms in addition to inflammatory arthritis and they haven’t responded to disease modifying anti-rheumatic drugs (DMARDs), anti-CD20 therapy like rituximab is a good choice,” explains Dr. DiRenzo.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“Tumor necrosis factor inhibitors can be a good option for synovitis when glandular symptoms don’t predominate,” adds Dr. Johr.

Dry Eye

When it comes to dry eye, both Drs. Johr and DiRenzo first stress the importance of co-managing with ophthalmology and obtaining an ocular staining sore (OSS) to understand how severe the dryness is.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“If possible, have the patient see a dry eye expert with a specific interest and expertise in dryness,” Dr. Johr notes.

Most of us know enough to recommend eye drops, such as preservative-free, single-use artificial tears, or prescription drops, such as cyclosporine or lifitegrast ophthalmic solutions. But what can we do as rheuma­tologists when those aren’t enough?

“A lot of patients don’t use thicker artificial tears (eye lubricants) at night, so that’s an easy place to start. Omega-3 fatty acid supplements are controversial since data for them is mixed, but our cornea specialists here at Penn find them helpful,” says Dr. Johr. “Intranasal varenicline has recently been approved by the FDA for dry eye, but a lot of people don’t know about it. There are no contraindications, but it’s expensive and and causes a lot of sneezing when first used.”

“A short course of steroid drops can accelerate healing in severe cases of dry eye, too,” says Dr. DiRenzo.

As for differential diagnosis, Dr. DiRenzo noted, “There’s an outstanding New England Journal of Medicine review on dry eye, and SjD only makes up a small portion of the causes.6 A more common cause is meibomian gland dysfunction, which is allergy driven. When allergies flare up, they clog the meibomian glands that make oil by the lash line. This oil is needed to make good tears—without it, tears evaporate too quickly, leading to dry eye. This is the cause of dry eye for many people, and there’s a specific treatment for this. Ophthalmologists can use perfluorohexyloctane ophthalmic solution [i.e., Miebo], allergy medications and warm compresses.”

Page: 1 2 3 4 | Single Page
Share: 

Filed under:Biologics/DMARDsConditionsDrug UpdatesSjögren’s Disease Tagged with:Clinical Practice GuidelinesDry eyeDry MouthfatigueHYDROXYCHLOROQUINEInterstitial Lung DiseaseMethotrexateneuropathyshared decision makingSjögren’s Disease supplement

Related Articles

    How to Diagnose Sjögren’s Disease

    August 26, 2025

    Improve your Sjögren’s disease diagnosis. Experts discuss objective testing, seronegative cases, ILD screening & management strategies.

    Sjögren’s Dry Eye Requires Collaboration Among Eye Doctors, Rheumatologists

    August 26, 2025

    Sjögren’s dry eye requires collaboration between rheumatologists and ophthalmologists for optimal patient management and treatment of this quality-of-life issue.

    New Options for Patients with Concurrent Dry Eye & Rheumatic Disease

    May 18, 2019

    Dry eye affects at least 30 million people in the U.S. and many more around the globe. Among patients with autoimmune disease—including Sjögren’s syndrome and rheumatoid arthritis—that number can climb even higher. Although dry eye may sound like just an annoyance, it can range from mildly irritating to debilitating, depending on the extent of the…

    How to Improve Oral & Eye Health in Sjögren’s Patients

    March 15, 2021

    ACR CONVERGENCE 2020—Sjögren’s syndrome requires care from several specialists, and presenters at the Sjögren’s Syndrome: Dental and Ocular Perspectives session shared diagnostic and treatment pearls from their respective specialties.  Rebecca Manno, MD, MHS, of the Comprehensive Arthritis and Rheumatology Center of the U.S. Virgin Islands moderated the session.  ad goes here:advert-1ADVERTISEMENTSCROLL TO CONTINUEOral Health Dry…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences